FI925590L - Expression av specifika immunogener genom anvaendning av virusantigener - Google Patents

Expression av specifika immunogener genom anvaendning av virusantigener Download PDF

Info

Publication number: FI925590L
Authority: FI; Finland
Prior art keywords: spekifika; immunogener; antigener; virus; expression
Prior art date: 1991-12-11

Application number

FI925590A

Other languages

English (en)

Finnish (fi)

Other versions

FI925590A0 (fi

Inventor

Paul Porwen Hung

Shaw-Guang Lin Lee

Narender Kumar Kalyan

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-11

Filing date

1992-12-09

Publication date

1993-06-12

1992-12-09 Application filed by American Home Prod filed Critical American Home Prod

1992-12-09 Publication of FI925590A0 publication Critical patent/FI925590A0/fi

1993-06-12 Publication of FI925590L publication Critical patent/FI925590L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

FI925590A 1991-12-11 1992-12-09 Expression av specifika immunogener genom anvaendning av virusantigener FI925590L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US80510591A	1991-12-11	1991-12-11

Publications (2)

Publication Number	Publication Date
FI925590A0 FI925590A0 (fi)	1992-12-09
FI925590L true FI925590L (fi)	1993-06-12

Family

ID=25190685

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI925590A FI925590L (fi)	1991-12-11	1992-12-09	Expression av specifika immunogener genom anvaendning av virusantigener

Country Status (17)

Country	Link
US (1)	US5591823A (zh)
EP (1)	EP0546787A3 (zh)
JP (1)	JPH05262667A (zh)
KR (1)	KR930013112A (zh)
CN (1)	CN1073878A (zh)
AU (1)	AU2981992A (zh)
BR (1)	BR9204978A (zh)
CA (1)	CA2084180A1 (zh)
CZ (1)	CZ362692A3 (zh)
FI (1)	FI925590L (zh)
HU (2)	HUT65366A (zh)
IL (1)	IL103928A0 (zh)
MX (1)	MX9207113A (zh)
NO (1)	NO924780L (zh)
SK (1)	SK362692A3 (zh)
TW (1)	TW239162B (zh)
ZA (1)	ZA929355B (zh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2215991T3 (es) *	1992-04-01	2004-10-16	The Rockefeller University	Procedimiento para la proliferacion (in vitro) de precursores de celulas dendriticas y su uso para producir inmunogenos.
CA2142007C (en) *	1992-08-11	2007-10-30	Robert Glen Urban	Immunomodulatory peptides
WO1995007099A1 (fr) *	1993-09-09	1995-03-16	The Nisshin Oil Mills, Ltd.	Vaccin et procede pour sa production
ES2370937T3 (es)	1993-09-13	2011-12-23	Protein Sciences Corporation	Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
EP2374894B1 (en) *	1993-09-13	2014-09-17	Protein Sciences Corporation	A method for producing influenza hemagglutinin multivalent vaccines
US5762939A (en) *	1993-09-13	1998-06-09	Mg-Pmc, Llc	Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
US6300090B1 (en)	1994-07-29	2001-10-09	The Rockefeller University	Methods of use of viral vectors to deliver antigen to dendritic cells
ATE386812T1 (de) *	1995-05-26	2008-03-15	Mg Pmc Llc	Methode für die produktion von multivalenten influenza hämagglutinin vakzinen
US7659119B2 (en)	1996-02-12	2010-02-09	Argos Therapeutics, Inc.	Method and compositions for obtaining mature dendritic cells
WO1998048834A1 (en) *	1997-04-30	1998-11-05	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
US6274378B1 (en)	1997-10-27	2001-08-14	The Rockefeller University	Methods and compositions for obtaining mature dendritic cells
JP2002504322A (ja)	1998-02-20	2002-02-12	ザロックフェラーユニバーシティー	樹状細胞に対するアポトーシス細胞介在抗原提示
WO2002026252A1 (fr) *	2000-08-10	2002-04-04	Tsinghua University	Vaccin contre le virus de la grippe et son procede de preparation
DE60116643T2 (de)	2000-09-11	2006-09-21	Dow Global Technologies, Inc., Midland	Notlaufreifen sowie farbstoff hierfür
EP1610757A4 (en) *	2003-04-10	2007-05-30	Transform Pharmaceuticals Inc	PROFILING OF CONFORMATIONAL VARIANTS, ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
US20090104216A1 (en) *	2005-06-01	2009-04-23	Variation Biotechnologies, Inc.	Peptide-Based Influenza Vaccine Formulation
CA2658227A1 (en)	2006-01-17	2007-07-26	Health Research, Inc.	Heteroduplex tracking assay
TWI494319B (zh) *	2007-02-21	2015-08-01	Oncotherapy Science Inc	表現腫瘤相關抗原之癌症的胜肽疫苗
EP2012122A1 (en) *	2007-07-06	2009-01-07	Medigene AG	Mutated parvovirus structural proteins as vaccines
US10004799B2 (en)	2007-08-27	2018-06-26	Longhorn Vaccines And Diagnostics, Llc	Composite antigenic sequences and vaccines
AU2008293504B2 (en)	2007-08-27	2012-04-12	Longhorn Vaccines & Diagnostics, Llc	Immunogenic compositions and methods
TW201008574A (en)	2008-08-19	2010-03-01	Oncotherapy Science Inc	INHBB epitope peptides and vaccines containing the same
EP2362906B1 (en)	2008-10-22	2015-04-08	Oncotherapy Science, Inc.	Rab6kifl/kif20a epitope peptide and vaccines containing the same
CN101708442B (zh) *	2009-09-04	2011-08-24	山东中惠仪器有限公司	全自动标准气体配制装置
CA2793959C (en)	2010-03-25	2019-06-04	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
PT2691530T (pt)	2011-06-10	2018-05-10	Univ Oregon Health & Science	Glicoproteínas e vectores recombinantes cmv
AU2012216792A1 (en)	2011-09-12	2013-03-28	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
ES2631608T3 (es)	2012-06-27	2017-09-01	International Aids Vaccine Initiative	Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en)	2013-09-05	2015-03-05	International Aids Vaccine Initiative	Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en)	2013-10-07	2017-05-31	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en)	2015-03-20	2019-01-08	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en)	2015-03-23	2016-09-28	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
AU2017215345B2 (en) *	2016-02-03	2023-10-19	Cg Discovery, Inc.	Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites
US10063211B2 (en) *	2016-02-03	2018-08-28	Qualcomm Incorporated	Compact bypass and decoupling structure for millimeter-wave circuits

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0339504A3 (en) *	1988-04-26	1990-09-12	The Du Pont Merck Pharmaceutical Company	Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5166057A (en) *	1989-08-28	1992-11-24	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant negative strand rna virus expression-systems
EP0492920A1 (en) *	1990-12-24	1992-07-01	Merck & Co. Inc.	Chimaeric influenza-HIV vaccine

1992
- 1992-11-30 CA CA002084180A patent/CA2084180A1/en not_active Abandoned
- 1992-11-30 IL IL103928A patent/IL103928A0/xx unknown
- 1992-12-01 JP JP4321768A patent/JPH05262667A/ja active Pending
- 1992-12-02 AU AU29819/92A patent/AU2981992A/en not_active Abandoned
- 1992-12-02 ZA ZA929355A patent/ZA929355B/xx unknown
- 1992-12-07 TW TW081109778A patent/TW239162B/zh active
- 1992-12-07 EP EP19920311146 patent/EP0546787A3/en not_active Withdrawn
- 1992-12-09 KR KR1019920023656A patent/KR930013112A/ko not_active Application Discontinuation
- 1992-12-09 FI FI925590A patent/FI925590L/fi not_active Application Discontinuation
- 1992-12-09 MX MX9207113A patent/MX9207113A/es unknown
- 1992-12-10 CZ CS923626A patent/CZ362692A3/cs unknown
- 1992-12-10 CN CN92113703A patent/CN1073878A/zh active Pending
- 1992-12-10 NO NO92924780A patent/NO924780L/no unknown
- 1992-12-10 SK SK3626-92A patent/SK362692A3/sk unknown
- 1992-12-10 BR BR9204978A patent/BR9204978A/pt not_active Application Discontinuation
- 1992-12-11 HU HU9203931A patent/HUT65366A/hu unknown
1993
- 1993-12-17 US US08/169,813 patent/US5591823A/en not_active Expired - Lifetime
1995
- 1995-06-27 HU HU95P/P00456P patent/HU211548A9/hu unknown

Also Published As

Publication number	Publication date
CA2084180A1 (en)	1993-06-12
ZA929355B (en)	1994-06-02
TW239162B (zh)	1995-01-21
KR930013112A (ko)	1993-07-21
EP0546787A3 (en)	1994-06-01
SK362692A3 (en)	1995-11-08
CZ362692A3 (en)	1994-02-16
IL103928A0 (en)	1993-04-04
HU9203931D0 (en)	1993-04-28
HU211548A9 (en)	1995-12-28
AU2981992A (en)	1993-06-17
HUT65366A (en)	1994-05-02
FI925590A0 (fi)	1992-12-09
CN1073878A (zh)	1993-07-07
US5591823A (en)	1997-01-07
BR9204978A (pt)	1993-06-15
NO924780L (no)	1993-06-14
EP0546787A2 (en)	1993-06-16
MX9207113A (es)	1994-05-31
JPH05262667A (ja)	1993-10-12
NO924780D0 (no)	1992-12-10

Publication	Publication Date	Title
FI925590L (fi)	1993-06-12	Expression av specifika immunogener genom anvaendning av virusantigener
FI924146L (fi)	1993-03-18	Foerfarande foer framstaellning av aminosyror genom fermentering
FI925028L (fi)	1993-05-09	Foerfarande foer framstaellning av en kompositionsprodukt genom malning
FI923743L (fi)	1992-08-20	Med ultraljud effektiverat foerfarande foer levererande av materialer genom huden
FI914703L (fi)	1993-04-05	Foerfarande foer framstaellning av en silprodukt och genom foerfarandet framstaelld silprodukt
FI920175L (fi)	1992-07-17	Foerfarande foer framstaellning av additionspolymerisationskatalysatorer genom oxidering av metallkaernan.
FI933982L (fi)	1993-09-10	Framstaellning av dieselbraensle genom hydrering av ett dieselmatningsmaterial
FI903443A0 (fi)	1990-07-06	Framstaellning av lackas genom rekombinantorganismer.
FI931487L (fi)	1993-10-04	Foerfarande foer framstaellning av myrsyra genom termisk soenderdelning avkvaternaera ammoniumformiat
FI932025L (fi)	1993-06-07	Asialoglykoproteiner av hepatit-C-virus
FI921945L (fi)	1992-10-31	Foerfaranden foer amplifiering och detektering av nukleinsyror genom attanvaenda snabb polymeraskedjereaktionscykel
FI933893L (fi)	1993-09-06	Saenkning av kolesterolhalten i blod genom cellulosaetrar
FI945397A0 (fi)	1994-11-16	Foerbaettrad syrsaettning av talloljetvaol genom anvaendning av koldioxid
FI924306L (fi)	1993-03-28	Foerbaettrat vaevnadslim som framstaellts genom anvaendning av kryofaellning
FI921523L (fi)	1992-10-10	Foerfarande foer framstaellning av ginkgolid b fraon ginkgolid c
NO921761D0 (no)	1992-05-05	Sentrifugalorgan
FI924547L (fi)	1993-04-09	Foerfarande, testanordning och testfoerpackning foer bestaemning av en specifik bindningsligand genom anvaendning av reglerad stroemning genom en filtreringsmembran
FI920988L (fi)	1992-09-09	Foerfarande foer rengoerning av vatten genom nitrifisering och denitrifisering
FI935200L (fi)	1994-05-26	Foerfarande och formmassa foer framstaellning av oorganiska sintringsprodukter genom formsprutning
FI921330L (fi)	1992-09-28	Foerfarande foer framstaellning av pentafluoretan genom hydrering av klorpentafluoretan i aongfas
FI925876L (fi)	1993-06-25	Foerfarande foer framstaellning av ett virusinaktiverat protrombinkomplexkoncentrat
FI934446L (fi)	1993-10-29	Foerfarande foer reducering av maengden av faergade aemnen i blekavlut genom att anvaenda dzd-blekserie
FI934777A (fi)	1993-10-28	Multipel hepatitis b virus ytproteiner som bildar partiklar
FI923191A (fi)	1993-01-12	Foerfarande foer kompensering av saendarens am/pm-foervraengning genom modulering av lokaloskillatorns fas och en daermed associerad kompenseringskrets
FI923799L (fi)	1993-02-25	Foerfarande foer framstaellning av metylacetat

Legal Events

Date	Code	Title	Description
1997-07-14	FD	Application lapsed